Pathogenic contribution of lipid homeostasis to chagasic Cardiomyopathy
脂质稳态对恰加斯心肌病的致病作用
基本信息
- 批准号:9188826
- 负责人:
- 金额:$ 41.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-04-01 至 2019-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdipocytesAdipose tissueAffectAffinityApolipoproteins BApoptosisAreaAustraliaBiogenesisCETP geneCardiacCardiac MyocytesCardiomyopathiesCase StudyCell DeathCellsChagas DiseaseCholesterolChronicCountryDataDepositionDeveloped CountriesDevelopmentDiabetes MellitusDiseaseEarly InterventionEconomic BurdenEnergy-Generating ResourcesEuropeFatty AcidsFatty acid glycerol estersFrequenciesGenetic TranscriptionGoalsHealthHealthcare SystemsHeartHeart DiseasesHomeostasisHumanImmigrantImmigrationInfectionInterventionInvadedLDL Cholesterol LipoproteinsLatin AmericaLeadLinkLipidsLipodystrophyLipolysisLipoproteinsLow Density Lipoprotein ReceptorMammalian CellMediatingMetabolicMitochondriaModelingMorbidity - disease rateMusMyocarditisMyocardiumNecrosisNorth AmericaObesityOrganOutcomeOxidative StressParasitemiaParasitesPathogenesisPathologyPatientsPharmaceutical PreparationsPhasePhysiologyPlayResearchRiskRoleSerumSouth AmericaStagingStressTissuesTransgenic OrganismsTrypanosoma cruziUnited StatesVaccinesWorld Health Organizationbasechagasic cardiomyopathylipid biosynthesislipid metabolismlow density lipoprotein inhibitormitochondrial dysfunctionmortalitymouse modelneglected tropical diseasesnovel strategiesparasite invasionpathogenprevent
项目摘要
DESCRIPTION (provided by applicant): Chagasic Cardiomyopathy (CCM) caused by the intracellular protozoan Trypanosoma cruzi is a major cause of mortality and morbidity in the endemic regions of Latin America with an estimated 15 million infected with or are carriers of the disease. Globalization has increased the risk of Chagas disease in developed countries including North America, Europe and Australia. We demonstrated that elevated cholesterol increased the rate of T. cruzi invasion and that this parasite utilizes LDLr to invade host cells. Parasite invasion was associated with a significant increase in the levels of LDL in organs such as heart and adipose tissue. Our studies reveal that : (i) T. cruzi targets adipose tissue (AT) during acute infection which acts as an energy source and reservoir for this parasite, (ii) In AT acute infection results in a significant decrease in fatty acid and an increase in cholesterol, and
importantly a significant level of lipolysis (fat loss) and fat cell necrosis, (iii) Lipolysis resuts in increased serum lipid levels and parasitemia (serum parasite level) during acute stage of infection both of which significantly decrease by the end of acute infection, (iv) By the end of acute stage of infection, cardiac lipid levels and parasite load are significantly increased, (v) Elevated expression of SREBPs and cholesterol levels in the myocardium associate with the indeterminate stage of infection, (vi) Cardiac cholesterol levels are still elevated during chronic
infection, and (vii) ER and mitochondrial oxidative stress is associated with acute infection and persists to chronic stage in murine chagas model. Lipodystrophy and elevated cardiac cholesterol is observed in CCM patients. This suggests that interlinked AT-cardiac lipid metabolism play a major role in the development of CCM. However, the exact mechanisms through which T. cruzi alter AT-cardiac lipid metabolism at different stages of infection is not known. Based on these observations we hypothesize that chronic CCM is developed through two distinct perturbations in lipid metabolism; (1) acute infection-induced increase in lipolysis and lipid influx to myocardium, and (2) Indeterminate (intermediate) stage infection-associated induction of de novo lipogenesis in myocardium. In short, we propose that adipose tissue lipolysis regulates cardiac lipid deposition, and the altered cardiac lipid homeostasis results in CCM. The overall goal of this proposal is to investigate the mechanistic link between AT and cardiac lipid metabolism in the progression of CCM during different stages of T. cruzi infection. In order to fully appreciate the role of adipocytes and Lipoproteins in the pathogenesis of human CCM we are using transgenic "FAT-ATTAC" and double transgenic "CETP-ApoB" mice respectively. Understanding the factors responsible for chronic CCM will aid in the development of new approaches to prevent progression of Chagasic heart disease for which currently no vaccine or effective drug available.
描述(由申请人提供):由细胞内原生动物克氏锥虫引起的恰加斯型心肌病(CCM)是拉丁美洲流行地区死亡和发病的主要原因,估计有1500万人感染或携带该疾病。全球化增加了包括北美、欧洲和澳大利亚在内的发达国家发生恰加斯病的风险。我们证明了升高的胆固醇增加了克氏锥虫的入侵率,这种寄生虫利用LDLr入侵宿主细胞。寄生虫入侵与心脏和脂肪组织等器官中低密度脂蛋白水平的显著增加有关。我们的研究表明:(1)克氏锥虫在急性感染期间以脂肪组织(AT)为目标,AT是这种寄生虫的能量来源和储存库;(2)AT急性感染导致脂肪酸显著减少和胆固醇升高
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jyothi Falguni Nagajyothi其他文献
Jyothi Falguni Nagajyothi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jyothi Falguni Nagajyothi', 18)}}的其他基金
Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue
脂肪组织对肺结核发病机制的免疫代谢调节
- 批准号:
10227530 - 财政年份:2020
- 资助金额:
$ 41.42万 - 项目类别:
Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue
脂肪组织对肺结核发病机制的免疫代谢调节
- 批准号:
10237418 - 财政年份:2020
- 资助金额:
$ 41.42万 - 项目类别:
Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue
脂肪组织对肺结核发病机制的免疫代谢调节
- 批准号:
10320075 - 财政年份:2020
- 资助金额:
$ 41.42万 - 项目类别:
Immunometabolic regulations of pulmonary TB pathogenesis by adiposetissue
脂肪组织对肺结核发病机制的免疫代谢调节
- 批准号:
10539249 - 财政年份:2020
- 资助金额:
$ 41.42万 - 项目类别:
Pathogenic contribution of lipid homeostasis to chagasic Cardiomyopathy
脂质稳态对恰加斯心肌病的致病作用
- 批准号:
9172479 - 财政年份:2015
- 资助金额:
$ 41.42万 - 项目类别:
Pathogenic contribution of lipid homeostasis to chagasic Cardiomyopathy
脂质稳态对恰加斯心肌病的致病作用
- 批准号:
9127659 - 财政年份:2015
- 资助金额:
$ 41.42万 - 项目类别:
Role of Lipoproteins in Chagasic heart disease
脂蛋白在恰加斯心脏病中的作用
- 批准号:
8385373 - 财政年份:2012
- 资助金额:
$ 41.42万 - 项目类别:
Role of Lipoproteins in Chagasic heart disease
脂蛋白在恰加斯心脏病中的作用
- 批准号:
8511513 - 财政年份:2012
- 资助金额:
$ 41.42万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 41.42万 - 项目类别:
Research Grant














{{item.name}}会员




